THE PRESENT INVENTION RELATES TO CURE OR TREATMENT OR MAINTENANCE OR PREVENTION THERAPIES FOR NORMAL OR DRUG RESISTANCE HIV INFECTIONS WITH OR WITHOUT CURRENTLY AVAILABLE ANTIRETROVIRAL CHEMOTHERAPIES. THE BIOLOGICAL MOLECULES OR SYNTHETIC MOLECULES ARE REFERRED TO IN THE PRESENT INVENTION ARE EITHER A MIXTURE OF POLYCLONAL SERUM, MONOCLONAL ANTIBODIES, CHIMERIC MONOCLONAL ANTIBODIES. THESE MOLECULES CAN BE COMPLETE MOLECULES OR A PORTION OF THEM.THESE MOLECULES AS A MINIMUM IMMUNE-MODULATE THE IMMUNE SYSTEM AND INCREASE EFFECT OF CURRENTLY AVAILABLE RETI-OVIRAL THERAPY BY REDUCING OR ELIMINATING THE VIRAL RESISTANCE TO THERAPY OR FASTER VIRUS ELIMINATION. THESE MIXTURES AND FORMULATION CAN ULTIMATELY LEAD TO CURE OR TREATMENT AND EVEN PREVENTING AN INFECTION FROM HIV. INVENTION ALSO RELATES TO THE FORMULATION & COMPOSITION OF THE ANTIRETROVIRAL THERAPIES BOOSTERS AND THEIR MODE OF ACTION AND ROUTE OF ADMINISTRATION.
